Transdermal drug delivery system and method

• US 20010023330A1
• Filed: 04/19/2001
• Published: 09/20/2001
• Est. Priority Date: 03/08/1999
• Status: Abandoned Application

• Current Assignee: Yoram Palti
• Original Assignee: Yoram Palti
• Inventors: Palti, Yoram
• Application Number:
  US09/838,105
• Publication Number:
  US 20010023330A1
• Time in Patent Office: Days
• US Class Current: 604/20
• CPC Class Codes: A61N 1/044 Shape of the electrode
• CPC Class Codes: A61N 1/0444 Membrane
• CPC Class Codes: A61N 1/325 for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body electrodes for external use A61N1/0428

Abstract

A transdermal iontophoresis electrode assembly includes one or more arrays of electrodes separated by dividing members. The spacing between the electrodes and/or the size of the electrodes is adjusted for controlling depth of penetration and current density. An alternative electrode assembly includes a housing, an electrode within the housing, a membrane covering an open end of the housing, a drug to be administered disposed within the housing, and an insulating layer covering the open end of the housing. The insulating layer includes apertures for channeling current passed through the electrode. The sizes of the apertures may be adjusted for achieving a desired depth of penetration or current density. In transdermal iontophoresis methods, relational criteria relating i) AC frequency/pulse duration to nerve or muscle tissue stimulation, ii) maximum current density to skin burning, iii) ionic concentration to depth of penetration and AC frequency/pulse duration, and iv) electrode size to current density, are used to determine operational criteria for carrying out transdermal iontophoresis. In a transdermal iontophoresis system the electrical signal used to perform transdermal iontophoresis is an AC signal having a frequency of greater than 100 Hz, or an alternating signal having a pulse duration of less than 2 milliseconds. In a further transdermal iontophoresis system, the ionic concentration of the drug is varied to achieve a desired depth of penetration.

Claims

1. A transdermal iontophoresis electrode comprising:

a housing having an interior and an open end extending from the interior of the housing to an exterior of the housing;

an electrode disposed within the housing; and

an insulating layer disposed adjacent to the open end of the housing, the insulating layer comprising at least one aperture extending therethrough, the at least one aperture having a cross-sectional area less than the cross-sectional area of the open end of the housing.

2. The transdermal iontophoresis electrode according to

claim 1

wherein the size of the aperture is selected to achieve a desired depth of penetration.

3. The transdermal iontophoresis electrode according to

claim 1

further comprising a plurality of apertures extending through the insulting layer, the combined cross-sectional area of the apertures being less than the cross-sectional area of the open end of the housing.

4. The transdermal iontophoresis electrode according to

claim 3

wherein the size of each aperture is selected to achieve a desired depth of penetration.

5. The transdermal iontophoresis electrode according to

claim 1

further comprising a membrane adjacent to the open end of housing.

6. The transdermal iontophoresis electrode according to

claim 1

further comprising at least one dividing member within the housing defining a plurality of channels within the housing, each channel having an interior and an open end extending from the interior of the channel to an exterior of the channel;

and

the insulating layer comprising at least one aperture adjacent to the open end of at least one channel, the aperture having a cross-sectional area less than the cross-sectional area of the open end of the at least one channel.

7. The transdermal iontophoresis electrode according to

claim 6

wherein the insulating layer comprises at least one aperture adjacent to the open end of each channel, each aperture having a cross-sectional area less than the cross-sectional area of the open end of its respective channel.

9. The transdermal iontophoresis electrode according to

claim 7

wherein the insulating layer comprises at least one aperture adjacent to the open end of each channel, each aperture having a cross-sectional area less than the cross-sectional area of the open end of its respective channel.

8. A transdermal iontophoresis electrode assembly comprising:

a housing;

at least one dividing member within the housing defining a plurality of channels within the housing, each channel having an interior and an open end extending from the interior of the channel to an exterior of the channel; and

an insulating layer adjacent to the open end of the housing, the insulating layer comprising at least one aperture adjacent to the open end of at least one channel, the aperture having a cross-sectional area less than the cross-sectional area of the open end of the at least one channel.

10. The transdermal iontophoresis electrode according to

claim 8

wherein the size of the aperture is selected to achieve a desired depth of penetration.

11. A transdermal iontophoresis electrode comprising a housing having an interior and an open end extending from the interior of the housing to an exterior of the housing, the interior having a cross-section, the open end comprising an aperture having a cross-section smaller than the cross-section of the interior.

12. The transdermal iontophoresis electrode according to

claim 11

wherein the size of the aperture is selected to achieve a desired depth of penetration.